Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907

PURPOSE: CALGB 49907 showed the superiority of standard therapy, which included either cyclophosphamide/doxorubicin (AC) or cyclophosphamide/methotrexate/fluorouracil over single-agent capecitabine in the treatment of patients age ≥ 65 with early-stage breast cancer. The treatment allowed dosing adj...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Oncol
Autors principals: Lichtman, Stuart M., Cirrincione, Constance T., Hurria, Arti, Jatoi, Aminah, Theodoulou, Maria, Wolff, Antonio C., Gralow, Julie, Morganstern, Daniel E., Magrinat, Gustav, Cohen, Harvey Jay, Muss, Hyman B.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2016
Matèries:
ORIGINAL REPORTS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4872024/
https://ncbi.nlm.nih.gov/pubmed/26755510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.62.6341
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars